Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19

Abstract
No abstract available
Funding Information
  • Kumamoto University (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • Japan Agency for Medical Research and Development (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • SENSHIN Medical Research Foundation (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • Institute for Frontier Life and Medical Sciences, Kyoto University (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • Japan Society for the Promotion of Science (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • Core Research for Evolutional Science and Technology (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)
  • Ministry of Education, Culture, Sports, Science and Technology (19fk0108111j, 20fk0108270h0001, JP20fk0108271, 20356730, 20H05773, 20K20596)